Copyright Reports & Markets. All rights reserved.

Global Sicca Syndrome Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Sicca Syndrome Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Sicca Syndrome Drug Market Size Growth Rate by Product
      • 1.4.2 BMS-986142
      • 1.4.3 Belimumab
      • 1.4.4 Coversin
      • 1.4.5 Filgotinib
      • 1.4.6 LY-3090106
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Sicca Syndrome Drug Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Sicca Syndrome Drug Market Size
      • 2.1.1 Global Sicca Syndrome Drug Revenue 2014-2025
      • 2.1.2 Global Sicca Syndrome Drug Sales 2014-2025
    • 2.2 Sicca Syndrome Drug Growth Rate by Regions
      • 2.2.1 Global Sicca Syndrome Drug Sales by Regions
      • 2.2.2 Global Sicca Syndrome Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Sicca Syndrome Drug Sales by Manufacturers
      • 3.1.1 Sicca Syndrome Drug Sales by Manufacturers
      • 3.1.2 Sicca Syndrome Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Sicca Syndrome Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Sicca Syndrome Drug Revenue by Manufacturers
      • 3.2.1 Sicca Syndrome Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Sicca Syndrome Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Sicca Syndrome Drug Price by Manufacturers
    • 3.4 Sicca Syndrome Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Sicca Syndrome Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Sicca Syndrome Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Sicca Syndrome Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Sicca Syndrome Drug Sales by Product
    • 4.2 Global Sicca Syndrome Drug Revenue by Product
    • 4.3 Sicca Syndrome Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Sicca Syndrome Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Sicca Syndrome Drug by Countries
      • 6.1.1 North America Sicca Syndrome Drug Sales by Countries
      • 6.1.2 North America Sicca Syndrome Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Sicca Syndrome Drug by Product
    • 6.3 North America Sicca Syndrome Drug by End User

    7 Europe

    • 7.1 Europe Sicca Syndrome Drug by Countries
      • 7.1.1 Europe Sicca Syndrome Drug Sales by Countries
      • 7.1.2 Europe Sicca Syndrome Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Sicca Syndrome Drug by Product
    • 7.3 Europe Sicca Syndrome Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Sicca Syndrome Drug by Countries
      • 8.1.1 Asia Pacific Sicca Syndrome Drug Sales by Countries
      • 8.1.2 Asia Pacific Sicca Syndrome Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Sicca Syndrome Drug by Product
    • 8.3 Asia Pacific Sicca Syndrome Drug by End User

    9 Central & South America

    • 9.1 Central & South America Sicca Syndrome Drug by Countries
      • 9.1.1 Central & South America Sicca Syndrome Drug Sales by Countries
      • 9.1.2 Central & South America Sicca Syndrome Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Sicca Syndrome Drug by Product
    • 9.3 Central & South America Sicca Syndrome Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Sicca Syndrome Drug by Countries
      • 10.1.1 Middle East and Africa Sicca Syndrome Drug Sales by Countries
      • 10.1.2 Middle East and Africa Sicca Syndrome Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Sicca Syndrome Drug by Product
    • 10.3 Middle East and Africa Sicca Syndrome Drug by End User

    11 Company Profiles

    • 11.1 Akari Therapeutics, Plc
      • 11.1.1 Akari Therapeutics, Plc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Akari Therapeutics, Plc Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Akari Therapeutics, Plc Sicca Syndrome Drug Products Offered
      • 11.1.5 Akari Therapeutics, Plc Recent Development
    • 11.2 Amgen Inc.
      • 11.2.1 Amgen Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Amgen Inc. Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Amgen Inc. Sicca Syndrome Drug Products Offered
      • 11.2.5 Amgen Inc. Recent Development
    • 11.3 Ampio Pharmaceuticals, Inc.
      • 11.3.1 Ampio Pharmaceuticals, Inc. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Products Offered
      • 11.3.5 Ampio Pharmaceuticals, Inc. Recent Development
    • 11.4 Biogen, Inc.
      • 11.4.1 Biogen, Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Biogen, Inc. Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Biogen, Inc. Sicca Syndrome Drug Products Offered
      • 11.4.5 Biogen, Inc. Recent Development
    • 11.5 Bristol-Myers Squibb Company
      • 11.5.1 Bristol-Myers Squibb Company Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Bristol-Myers Squibb Company Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Bristol-Myers Squibb Company Sicca Syndrome Drug Products Offered
      • 11.5.5 Bristol-Myers Squibb Company Recent Development
    • 11.6 GlaxoSmithKline Plc
      • 11.6.1 GlaxoSmithKline Plc Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 GlaxoSmithKline Plc Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 GlaxoSmithKline Plc Sicca Syndrome Drug Products Offered
      • 11.6.5 GlaxoSmithKline Plc Recent Development
    • 11.7 MedImmune, LLC
      • 11.7.1 MedImmune, LLC Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 MedImmune, LLC Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 MedImmune, LLC Sicca Syndrome Drug Products Offered
      • 11.7.5 MedImmune, LLC Recent Development
    • 11.8 Novartis AG
      • 11.8.1 Novartis AG Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Novartis AG Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Novartis AG Sicca Syndrome Drug Products Offered
      • 11.8.5 Novartis AG Recent Development
    • 11.9 Redx Pharma Plc
      • 11.9.1 Redx Pharma Plc Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Redx Pharma Plc Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Redx Pharma Plc Sicca Syndrome Drug Products Offered
      • 11.9.5 Redx Pharma Plc Recent Development
    • 11.10 Toleranzia AB
      • 11.10.1 Toleranzia AB Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Toleranzia AB Sicca Syndrome Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Toleranzia AB Sicca Syndrome Drug Products Offered
      • 11.10.5 Toleranzia AB Recent Development
    • 11.11 UCB S.A.

    12 Future Forecast

    • 12.1 Sicca Syndrome Drug Market Forecast by Regions
      • 12.1.1 Global Sicca Syndrome Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Sicca Syndrome Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Sicca Syndrome Drug Market Forecast by Product
      • 12.2.1 Global Sicca Syndrome Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Sicca Syndrome Drug Revenue Forecast by Product 2019-2025
    • 12.3 Sicca Syndrome Drug Market Forecast by End User
    • 12.4 North America Sicca Syndrome Drug Forecast
    • 12.5 Europe Sicca Syndrome Drug Forecast
    • 12.6 Asia Pacific Sicca Syndrome Drug Forecast
    • 12.7 Central & South America Sicca Syndrome Drug Forecast
    • 12.8 Middle East and Africa Sicca Syndrome Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Sicca Syndrome Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Sicca Syndrome Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sicca Syndrome Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Sicca Syndrome Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sicca Syndrome Drug in these regions.
      This research report categorizes the global Sicca Syndrome Drug market by top players/brands, region, type and end user. This report also studies the global Sicca Syndrome Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Akari Therapeutics, Plc
      Amgen Inc.
      Ampio Pharmaceuticals, Inc.
      Biogen, Inc.
      Bristol-Myers Squibb Company
      GlaxoSmithKline Plc
      MedImmune, LLC
      Novartis AG
      Redx Pharma Plc
      Toleranzia AB
      UCB S.A.

      Market size by Product
      BMS-986142
      Belimumab
      Coversin
      Filgotinib
      LY-3090106
      Others
      Market size by End User
      Hospital
      Clinic
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Sicca Syndrome Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Sicca Syndrome Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Sicca Syndrome Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Sicca Syndrome Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Sicca Syndrome Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sicca Syndrome Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now